Analysen von Marc Goodman

11.11.11 Merck buy UBS AG
31.10.11 Merck buy UBS AG
27.10.11 Bristol-Myers Squibb neutral UBS AG
05.10.11 Teva Pharmaceutical Industries buy UBS AG
03.10.11 Bausch Health buy UBS AG
22.09.11 Bausch Health buy UBS AG
04.08.11 Merck buy UBS AG
03.08.11 Teva Pharmaceutical Industries buy UBS AG
03.08.11 Pfizer buy UBS AG
03.08.11 Teva Pharmaceutical Industries buy UBS AG
28.07.11 Teva Pharmaceutical Industries buy UBS AG
27.06.11 Bristol-Myers Squibb neutral UBS AG
23.06.11 Bristol-Myers Squibb neutral UBS AG
14.06.11 Bausch Health buy UBS AG
12.05.11 Teva Pharmaceutical Industries buy UBS AG
03.05.11 Teva Pharmaceutical Industries buy UBS AG
26.04.11 Teva Pharmaceutical Industries buy UBS AG
11.04.11 Bausch Health buy UBS AG
09.02.11 Teva Pharmaceutical Industries buy UBS AG
03.02.11 Teva Pharmaceutical Industries buy UBS AG
26.01.11 Teva Pharmaceutical Industries buy UBS AG
07.01.11 Bausch Health buy UBS AG
14.09.10 Novartis buy UBS AG
08.09.10 Bausch Health buy UBS AG
31.08.10 Bausch Health buy UBS AG
12.08.10 Bausch Health buy UBS AG
28.07.10 Bausch Health buy UBS AG